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传代，用状态稳定良好的 2-5 代细胞实验。 
2.实验分组：第一部分：用不同浓度或不同时间的大鼠炎症因子白介素-1 ß 
（IL - 1ß）诱导出平滑肌细胞高表达 IIA 型分泌型磷脂酶 A2 作为模型；第
二部分：给予细胞洛伐他汀或辛伐他汀培养不同浓度或不同时间；第三部分：
在 IL - 1ß20ng/ml 存在条件下，分别给予不同浓度或时间的洛伐他汀孵育；
第四部分：在有 IL - 1ß20ng/ml 诱导的前提下，分别给予细胞不同浓度或
时间的血脂康  共孵育后收集细胞及上清液。 
3.取上清液分别用酶联免疫吸附实验 ELISA 和酶活性对比试剂检测 IIA 型
分泌型磷脂酶 A2 酶蛋白含量和活性，记录结果。 
4.收集细胞，提取 RNA,逆转录成 cDNA,再以荧光实时定量 PCR 检测 IIA 型分























量的sPLA2 -IIA。第一部分：IL - 1ß（10,20,50,100ng/ml）刺激组能诱导
sPLA2 -IIA mRNA、蛋白含量及酶活性比对照组，均明显增加，且有显著差














1． 他汀和IL - 1ß均能分别温和刺激大鼠血管平滑肌细胞中sPLA2 –IIA的
表达，但二者的联合能够协同强烈刺激sPLA2 –IIA mRNA，酶含量及活性的
高表达； 
2． 与他汀效应不同，血脂康能降低IL - 1ß刺激下大鼠血管平滑肌细胞中
sPLA2 –IIA mRNA，酶含量及活性的表达。 
 
















Atherosclerosis is a multifactorial vascular disease characterized by formation of 
inflammatory lesions. Secretory phospholipase A2, group IIA (sPLA2-IIA) involves 
in this process and plays a certain anti-inflammatory role in it. Both Statins and 
Xuezhikang are widely used in the prevention and treatment of cardiovascular disease 
risk because of their pleiotropic effects on the cardiovascular system. However, the 
effect on sPLA2-IIA remains μnclear. Therefore we investigated the regμlation of 
sPLA2-IIA by statins and XZK in rat thoracic aorta smooth muscel cells (VSMCs) 
andfurtherproviding theory basis for the use of the two drugs in cardiovascular 
disease. 
Methods 
1.Cells culture: Smooth muscle cells were isolated from the 130g~150g male 
Sprague-Dawley ratthoracic aortas, thencultivate 、identify and sub-culture of rat 
vascular smooth muscle cells.To the fifth passage of cells were used in experiments at 
most. 
2.The experimental groups: the first part:rat vascular smooth muscle 
cells(VSMCs) were tested for induction of sPLA2-IIA expression by IL-1ß for 
different concentrations or time and select the best culture condition for the 
expression of sPLA2-IIA in VSMCs as the experimental model.; the second 
part:VSMCs were respectively exposed to two kinds of stains( lovastatin 
and simvastatin) fordifferent concentrations or time; the third part: In the existence 
ofIL-1ß 20ng/ml, VSMCs were incubated with lovastatin for different concentrations 
or time; the forth part:In the existence ofIL-1ß 20ng/ml, VSMCs were incubated with 
















3. Take specific enzyme-linked immunosorbent assay (ELISA) kits and Assay of 
sPLA2 Activity to detect the content of sPLA2-IIA protein and enzymes activity in 
cell culture supernatants,respectively. Record the results. 
4. The cells used for the extraction of RNA, reverse transcription into cDNA, and 
then real-time fluorescent quantitative PCR into sPLA2-IIA mRNA. Record the 
results. 
5. Each experiment was performed at least 3 times.And data were analyzed by 
one-way ANOVA followed by Tukey’s Multiple Comparison Test. 
Results 
1.Identification of rat vascular smooth muscle cells: Morphological identification, 
under phase contrast microscope, the cell uniform distribution, local bundle cells in 
parallel, some area of the cell layers is overlapping, the ups and downs of the cells 
present a "peak and valley" growth. 
2.Smooth muscle cells specificity actin (against a-actin) immunohistochemical 
staining > 98% of cells staining positive, namely the cytoplasm rendered tan reaction, 
nucleus were not dyed. The appraisal result was rat vascular smooth muscle cells. 
3.The results of molecular biology: The control group without any stimulus, cells 
can express in very small amounts of sPLA2 - IIA. The first part: Compared with the 
control group, IL-1ß（10,20,50,100ng/ml）stimulated an increasing expression of 
sPLA2-IIA both at sPLA2-IIA mRNA、protein and activity levels, but only modest. 
And the data has statistically significant p<0.01; After exposed to 20ng/ml IL- 1ß for 
different time（6,12,24,36h） ,there was a time-dependent increasing manner in 
sPLA2-IIA expression in VSMCs, not only at sPLA2-IIA mRNA、protein levels, but 
also at activity level. And the data has statistically significant p<0.01. The second 
part:After VSMCs were respectively exposed to two kinds of stains(lovastatin 
and simvastatin) fordifferent concentrations （0.5,1,2μmol/l）or time(12,24,36h), we 
found that the sPLA2-IIA mRNA、protein and activity levels were significantly raised 
but slowly. The third part: In the existence ofIL-1ß 20ng/ml, VSMCs were incubated 
with lovastatin for different concentrations or time. Compared with the control group, 















orlovastatin alone, incubation of IL-1ß-treated cells with lovastatin consistently and 
dramatically increased sPLA2-IIA expression, especially in sPLA2-IIA mRNA. The 
forth part:In the existence ofIL-1ß 20ng/ml, VSMCs were incubated with XZK for 
various concentrations (25，50，100，200μg/ml)or time(12，24，36，48h). Compared 
with the control group, XZK groups increased sPLA2-IIA expression, but XZK could 
effectively decrease sPLA2-IIAexpression in the presence of IL-1ß in VSMCs in a 
dose and time-dependent manner when compared with model group, including in 
sPLA2-IIA mRNA, protein and activity. 
Conclusion 
1.Statins or IL-1β moderately increase the expression of sPLA2-IIA in VSMCs, 
and the combination of them significantly enhance the expression of  sPLA2-IIA 
mRNA、protein and enzymes activity. 
2.Different from the effects of statins, XZK could effectively reduce sPLA2-IIA 
expression in the presence of IL-1ß in VSMCs, including in sPLA2-IIA mRNA, 
protein and activity. 
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防治靶点对 AS 的干预具有重要意义。 
磷脂酶 A2（phospholipase A2，PLA2）是一类能催化脂蛋白和细胞膜上的甘
油磷脂二位酰基酯键水解形成非酯化脂肪酸和溶血磷脂的酶家族，含有十个亚




TNF-a, IL-1β, IL-6, and IFN-γ诱导可不同程度调节 sPLA2 –IIA 的分泌和
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